| Name | Walgreens #5170 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 8720 W Grand River Ave, Brighton, Michigan 48116 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (810) 225-4530 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
For years, the Medicare prescription drug benefit Part D has been credited with positively impacting national trends in health outcomes and medical services. But a recent study led by Northeastern associate professor Becky Briesacher challenges that assumption and suggests that the U.S. Congressional Budget Office's adopted a new costing method based on assumed cost-savings may be "premature."
Offenders enrolled in alcohol treatment programmes as part of their sentence are significantly less likely to be charged or reconvicted in the 12 months following their programme, a study led by Plymouth University has shown.
Meanwhile, a tea party challenger to Tennessee Sen. Lamar Alexander, the Republican incumbent, is focusing on his posture to the health care law, and House Speaker John Boehner said he plans to sue the president for misuse of executive powers on issues including health care.
Bioheart, Inc., (OTC Bulletin Board: BHRT) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and other cardiovascular diseases announced today that several of its Directors have joined the Company's executive management team. In addition to assuming the position of Chairman of the Company's Board of Directors, Karl E. Groth, Ph.D., became the Chief Executive Officer; Peggy A. Farley became Chief Operating Officer; and Mark P. Borman became Chief Financial Officer. Howard Leonhardt will continue as Chief Scientific and Technology Officer, and Chairman of the Scientific Advisory Board. Mr. Leonhardt, the Company's founder, thus will be able to focus on enhancing the Company's existing technologies and strengthening its position as the leader within the cardiovascular arena of the stem cell therapy industry.
› Verified 8 days ago
| NPI Number | 1740295880 |
| Organization Name | WALGREEN CO |
| Doing Business As | WALGREENS #05170 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 8720 W Grand River Ave, Brighton, MI 48116 |
| Phone Number | 810-225-3430 |
News Archive
For years, the Medicare prescription drug benefit Part D has been credited with positively impacting national trends in health outcomes and medical services. But a recent study led by Northeastern associate professor Becky Briesacher challenges that assumption and suggests that the U.S. Congressional Budget Office's adopted a new costing method based on assumed cost-savings may be "premature."
Offenders enrolled in alcohol treatment programmes as part of their sentence are significantly less likely to be charged or reconvicted in the 12 months following their programme, a study led by Plymouth University has shown.
Meanwhile, a tea party challenger to Tennessee Sen. Lamar Alexander, the Republican incumbent, is focusing on his posture to the health care law, and House Speaker John Boehner said he plans to sue the president for misuse of executive powers on issues including health care.
Bioheart, Inc., (OTC Bulletin Board: BHRT) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and other cardiovascular diseases announced today that several of its Directors have joined the Company's executive management team. In addition to assuming the position of Chairman of the Company's Board of Directors, Karl E. Groth, Ph.D., became the Chief Executive Officer; Peggy A. Farley became Chief Operating Officer; and Mark P. Borman became Chief Financial Officer. Howard Leonhardt will continue as Chief Scientific and Technology Officer, and Chairman of the Scientific Advisory Board. Mr. Leonhardt, the Company's founder, thus will be able to focus on enhancing the Company's existing technologies and strengthening its position as the leader within the cardiovascular arena of the stem cell therapy industry.
› Verified 8 days ago
News Archive
For years, the Medicare prescription drug benefit Part D has been credited with positively impacting national trends in health outcomes and medical services. But a recent study led by Northeastern associate professor Becky Briesacher challenges that assumption and suggests that the U.S. Congressional Budget Office's adopted a new costing method based on assumed cost-savings may be "premature."
Offenders enrolled in alcohol treatment programmes as part of their sentence are significantly less likely to be charged or reconvicted in the 12 months following their programme, a study led by Plymouth University has shown.
Meanwhile, a tea party challenger to Tennessee Sen. Lamar Alexander, the Republican incumbent, is focusing on his posture to the health care law, and House Speaker John Boehner said he plans to sue the president for misuse of executive powers on issues including health care.
Bioheart, Inc., (OTC Bulletin Board: BHRT) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and other cardiovascular diseases announced today that several of its Directors have joined the Company's executive management team. In addition to assuming the position of Chairman of the Company's Board of Directors, Karl E. Groth, Ph.D., became the Chief Executive Officer; Peggy A. Farley became Chief Operating Officer; and Mark P. Borman became Chief Financial Officer. Howard Leonhardt will continue as Chief Scientific and Technology Officer, and Chairman of the Scientific Advisory Board. Mr. Leonhardt, the Company's founder, thus will be able to focus on enhancing the Company's existing technologies and strengthening its position as the leader within the cardiovascular arena of the stem cell therapy industry.
› Verified 8 days ago
Physical Address Type: Durable Medical Equipment & Medical Supplies Supplier Location: 455 E Grand River Ave, Brighton, Michigan 48116 Phone: (888) 246-7667 | |
Rite Aid Pharmacy #04314 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 8701 W Grand River Ave, Brighton, Michigan 48116 Phone: (810) 220-5840 | |
Cvs Pharmacy #08204 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 106 W Grand River Ave, Brighton, Michigan 48116 Phone: (810) 220-8804 | |
Cvs Pharmacy #16346 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 8043 Challis Rd, Brighton, Michigan 48116 Phone: (810) 229-4264 | |
Cvs Pharmacy #08111 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5757 Whitmore Lake Rd, Brighton, Michigan 48116 Phone: (810) 229-9772 |